Moderate dose oral anticoagulant therapy in patients with the antiphospholipid syndrome? Yes.
Scully
M-F
MF
Faculty of Medicine, Health Sciences Centre, Memorial University of Newfoundland, St. John's, Newfoundland, Canada. dr.mary-francis.scully@hccsj.nf.ca
D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D016736:Antiphospholipid Syndrome / Q000188:drug therapy*; D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006470:Hemorrhage; D006801:Humans; D019934:International Normalized Ratio; D008403:Mass Screening; D014859:Warfarin / Q000008:administration & dosage / Q000627:therapeutic use
D000925:Anticoagulants; D014859:Warfarin; D001241:Aspirin